Advanced Molecular Imaging With Anti-3-[18F]FACBC PET-CT to Improve the Selection and Outcomes of Prostate Cancer Patients Receiving Post-prostatectomy Radiotherapy
Phase of Trial: Phase II/III
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 10 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 10 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
- 10 Jun 2017 Biomarkers information updated